Apeloa Pharmaceutical Co.,Ltd
000739
Rang in Aktien
#4330
Apeloa Pharmaceutical Co.,Ltd operates as a comprehensive pharmaceutical... Apeloa Pharmaceutical Co.,Ltd operates as a comprehensive pharmaceutical enterprise, specializing in the discovery, development, production, and global distribution of a diverse range of medicinal products. Its market reach spans China and various international territories. The company strategically focuses its product portfolio on several critical medical fields, including cardiovascular and cerebrovascular health, anti-infective treatments, antiviral therapies, and oncology (cancer treatment), alongside other therapeutic categories. Apeloa's offerings encompass finished pharmaceutical preparations, raw material intermediates (active pharmaceutical ingredients and their precursors), and veterinary medicines. These products are primarily recognized and sold under key brands such as Tianliwei, Beshin, Yosemade, and Jutai, among others. Furthermore, the company extends its expertise to other pharmaceutical businesses by providing contract research, development, and manufacturing (CDMO) services. The corporate headquarters for Apeloa Pharmaceutical Co.,Ltd are located in Dongyang, China.
Aktienkurs
$3.15
Zuletzt synchronisiert: 2026-10-20
Marktkapitalisierung
$3.65B
Veränderung (1 Tag)
0.46%
Veränderung (1 Jahr)
39.50%
Land
CN
Handel Apeloa Pharmaceutical Co.,Ltd (000739)
Kategorie
Healthcare
Operative Marge für Apeloa Pharmaceutical Co.,Ltd (000739)
Operative Marge zum October 2026 TTM: 10.18%
Laut den neuesten Finanzberichten und dem Aktienkurs von Apeloa Pharmaceutical Co.,Ltd beträgt die aktuelle operative Marge (TTM) 10.18%. Am Ende des Jahres 2023 lag die operative Marge bei 10.63%.
Historie der operativen Marge von Apeloa Pharmaceutical Co.,Ltd von 2000 bis 2026
Operative Marge zum Jahresende
| Jahr | Operative Marge | ändert |
|---|---|---|
| 2026 (TTM) | 10.18% | 0.99% |
| 2024 | 10.08% | -5.17% |
| 2023 | 10.63% | 10.84% |
| 2022 | 9.59% | -23.40% |
| 2021 | 12.52% | 1.71% |
| 2020 | 12.31% | 37.85% |
| 2019 | 8.93% | 16.12% |
| 2018 | 7.69% | 27.11% |
| 2017 | 6.05% | 5.58% |
| 2016 | 5.73% | 22.96% |
| 2015 | 4.66% | -42.54% |
| 2014 | 8.11% | 70.38% |
| 2013 | 4.76% | 15.53% |
| 2012 | 4.12% | -656.76% |
| 2011 | -0.74% | -153.24% |
| 2010 | 1.39% | -45.06% |
| 2009 | 2.53% | 18.78% |
| 2008 | 2.13% | -12.35% |
| 2007 | 2.43% | -54.49% |
| 2006 | 5.34% | 4.50% |
| 2005 | 5.11% | -12.80% |
| 2004 | 5.86% | -10.94% |
| 2003 | 6.58% | -13.08% |
| 2002 | 7.57% | -142.87% |
| 2001 | -17.66% | -746.89% |
| 2000 | 2.73% | 0.00% |
Operative Marge vergleichbarer Unternehmen oder Wettbewerber
| Unternehmen | Operative Marge | Differenz der operativen Marge | Land |
|---|---|---|---|
| 0.00% | - |
DE
|
|
| 0.00% | - |
DE
|
|
| 0.00% | - |
JP
|
|
| 0.00% | - |
CH
|
|
| 22.93% | -97.75% |
IN
|
Was ist die operative Marge eines Unternehmens?
Die operative Marge ist ein wichtiger Indikator zur Bewertung der Rentabilität eines Unternehmens. Höhere operative Margen sind in der Regel besser, da sie zeigen, dass ein Unternehmen seine Produkte oder Dienstleistungen mit deutlichem Gewinn über den Produktionskosten verkauft. Die operative Marge wird berechnet, indem der Gewinn des Unternehmens durch seinen Umsatz geteilt wird.